Form 4: National Healthcare Corp Executive Vicki L. Dodson Reports Stock Grant and Option Awards
SEC Form 4 Filing
Vicki L. Dodson, Sr. VP of Patient Services at National Healthcare Corp, reports the grant of restricted stock and stock option awards.
Summary
- On March 5, 2025, Vicki L. Dodson, Sr. VP Patient Services at National Healthcare Corp (NHC), reported transactions involving NHC's common stock.
- Dodson acquired 946 shares of common stock through a grant.
- Dodson now beneficially owns 7,546.5455 shares of common stock following the reported transactions.
- Dodson also holds options to purchase common stock at various exercise prices and expiration dates.
- These options include 3,734 shares exercisable at $63.96 expiring on 02/18/2027, 7,467 shares exercisable at $53.94 expiring on 03/08/2028, 12,000 shares exercisable at $94.1 expiring on 03/05/2029, and 13,500 shares exercisable at $90.62 expiring on 02/24/2030.
- The 946 restricted shares vest in three equal installments on 1/1/2026, 1/1/2027, and 1/1/2028.
Sentiment
Score: 6
Explanation: The sentiment is neutral. It's a routine disclosure of stock grants and option awards, which are standard components of executive compensation.
Positives
- The grant of restricted stock aligns Dodson's interests with those of the shareholders, incentivizing her to improve the company's performance.
- The vesting schedule encourages long-term commitment from Dodson.
Industry Context
Stock grants and options are common forms of executive compensation in the healthcare industry, aligning management's interests with shareholder value.
Comparison to Industry Standards
- Executive compensation packages, including stock options and restricted stock, are standard practice among publicly traded healthcare companies such as Brookdale Senior Living and HCA Healthcare.
- The vesting schedules and exercise prices are generally in line with industry norms for incentivizing long-term performance.
Stakeholder Impact
- The stock grant and option awards could potentially increase shareholder value if the executive's performance improves the company's financial results.
- Employees may view the executive's compensation positively, as it signals the company's commitment to rewarding leadership.
Key Dates
| Date | Description |
|---|---|
| 02/18/2023 | Date of option grant with expiration date 02/18/2027 and exercise price of $63.96. |
| 03/08/2024 | Date of option grant with expiration date 03/08/2028 and exercise price of $53.94. |
| 03/05/2025 | Date of transaction: Grant of restricted stock and stock options. |
| 03/05/2029 | Expiration date of options to purchase 12,000 shares at $94.1. |
| 02/24/2030 | Expiration date of options to purchase 13,500 shares at $90.62. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.